English | Español
Patient Daily | Mar 22, 2026

Pfizer reports phase 2 trial results for Ibrance successor in breast cancer treatment
Patient Daily | Mar 22, 2026

AI drug discovery platforms face new challenges in attracting investors
Patient Daily | Mar 22, 2026

Astellas ends partnership with CytomX despite positive early cancer drug data
Patient Daily | Mar 22, 2026

Rhythm’s Imcivree fails to meet main goal in late-stage obesity trial
Patient Daily | Mar 22, 2026

FDA issues third rejection for Aldeyra’s dry eye disease drug on March 17
Patient Daily | Mar 22, 2026

Federal judge blocks Kennedy’s vaccine policy overhaul, citing procedural failures
Patient Daily | Mar 22, 2026

FDA expands leucovorin use for rare disease amid scrutiny of regulatory standards
Patient Daily | Mar 22, 2026

Study links gut microbe molecules to coronary heart disease risk

Trending
+ Pharmaceuticals
Patient Daily | May 31, 2026

Roswell Park scientists to present five cancer studies at ASCO annual meeting
Patient Daily | Jun 5, 2026

National Breathe Free donates $175,000 to support shelter for Tampa Bay families
+ Regulatory
A. D. Alderman | Jun 3, 2026

New study says TikTok content may normalize illicit vaping among youth as Trump Administration ramps up enforcement
+ Pharmaceuticals
Patient Daily | Jun 1, 2026

Immuneering’s pancreatic cancer drug shows extended survival in Phase 2a trial